个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma (vol 9, 447, 2019)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Cheng, Fangling[1,2] * ; Zhang, Po[1,2] ; Xiao, Qungen[1] ; Li, Youwei[1,2] ; Dong, Minhai[1,2] ; Wang, Heping[1] ; Kuang, Dong[3,4] ; He, Yue[1] ; Duan, Qiuhong[5] ; Mao, Feng[1] ; Wang, Baofeng[1] ; Guo, Dongsheng[1] ;
单位： [1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept Neurosurg,Tongji Med Coll,Wuhan,Peoples R China [2]Huazhong Univ Sci & Technol,Chinese German Lab Mol Neurooncol,Tongji Hosp,Wuhan,Peoples R China [3]Huazhong Univ Sci & Technol,Inst Pathol,Tongji Hosp,Tongji Med Coll,Wuhan,Peoples R China [4]Huazhong Univ Sci & Technol, Sch Basic Med, Dept Pathol, Tongji Med Coll, Wuhan, Peoples R China [5]Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Peoples R China
出处：
DOI： 10.3389/fonc.2020.591112
ISSN：

关键词： glioma glioblastoma LRIG3 soluble LRIG3 MET/PI3K/Akt pathway prognosis

摘要：
[This corrects the article DOI: 10.3389/fonc.2019.00447.].Copyright © 2020 Cheng, Zhang, Xiao, Li, Dong, Wang, Kuang, He, Duan, Mao, Wang and Guo.

语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2025]版：
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区：
出版当年[2018]版：
Q2 ONCOLOGY
最新[2023]版：
Q2 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者：
第一作者单位： [1]Huazhong Univ Sci & Technol,Tongji Hosp,Dept Neurosurg,Tongji Med Coll,Wuhan,Peoples R China [2]Huazhong Univ Sci & Technol,Chinese German Lab Mol Neurooncol,Tongji Hosp,Wuhan,Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Cheng Fangling,Zhang Po,Xiao Qungen,et al.The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma (vol 9, 447, 2019)[J].FRONTIERS IN ONCOLOGY.2020,10:doi:10.3389/fonc.2020.591112.
APA：
Cheng, Fangling,Zhang, Po,Xiao, Qungen,Li, Youwei,Dong, Minhai...&Guo, Dongsheng.(2020).The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma (vol 9, 447, 2019).FRONTIERS IN ONCOLOGY,10,
MLA：
Cheng, Fangling,et al."The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma (vol 9, 447, 2019)".FRONTIERS IN ONCOLOGY 10.(2020)

相关文献

[1]The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma [2]LRIG3 AND SOLUBLE LRIG3 ECTODOMAIN BOTH INHIBIT THE PROLIFERATION AND INVASION OF GLIOMA CELLS IN VITRO AND IN VIVO THROUGH MODULATION OF MET-PI3K-AKT PATHWAY [3]Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma. [4]LRIG3 Suppresses Angiogenesis by Regulating the PI3K/AKT/VEGFA Signaling Pathway in Glioma [5]Overexpression of LRIG3 inhibits growth and invasion of malignant glioma cell [6]The heterogeneity of glioma stem cells [7]LRIG3 modulates proliferation, apoptosis and invasion of glioblastoma cells as a potent tumor suppressor [8]Effect of Over-expressed LRIG3 on Cell Cycle and Survival of Glioma Cells [9]Glioma-derived LRIG3 interacts with NETO2 in tumor-associated macrophages to modulate microenvironment and suppress tumor growth [10]Novel INHAT repressor drives glioblastoma growth by promoting ribosomal DNA transcription in glioma stem cells

资源点击量：434 今日访问量：0 总访问量：419 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）